HT
ROIV icon

Headlands Technologies’s Roivant Sciences ROIV Stock Holding History

Headlands Technologies’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-15,380
Closed -$426K – 946
2026
Q1 		$426K Sell
15,380
-54,063
-78% -$1.39M 0.05% 403
2025
Q4 		$1.51M Buy
+69,443
New +$1.37M 0.13% 191
2025
Q3 		– Sell
-162,003
Closed -$1.83M – 1143
2025
Q2 		$1.83M Buy
162,003
+160,651
+11,882% +$1.74M 0.22% 96
2025
Q1 		$13.6K Buy
+1,352
New +$14.6K ﹤0.01% 904
2024
Q1 		– Sell
-3,249
Closed -$36.5K – 1491
2023
Q4 		$36.5K Buy
+3,249
New +$31.7K 0.01% 579

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Headlands Technologies's ROIV Position: Q2 2026 in Review

Headlands Technologies sold out of Roivant Sciences (ROIV) in Q2 2026, closing a stake of 15,380 shares — an estimated $426K sold.

Headlands Technologies first reported a position in ROIV in Q4 2023 and held it in 5 quarters. The position peaked at $1.83M in Q2 2025. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Headlands Technologies reported no remaining Roivant Sciences position as of Q2 2026 after selling out during the quarter.
  • Headlands Technologies sold 15,380 Roivant Sciences shares in Q2 2026, an estimated $426K.
  • Headlands Technologies first reported a position in Roivant Sciences in Q4 2023 and held it in 5 quarters.
  • Headlands Technologies's Roivant Sciences position peaked at $1.83M in Q2 2025.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Headlands Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.